Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis.
about
The pathophysiology of thrombocytopenia in chronic liver diseaseNon-invasive diagnosis of liver fibrosis in chronic hepatitis CPreoperatively staging liver fibrosis using noninvasive method in hepatitis B virus-infected hepatocellular carcinoma patients.Performance of several simple, noninvasive models for assessing significant liver fibrosis in patients with chronic hepatitis BA brief review on molecular, genetic and imaging techniques for HCV fibrosis evaluation.Thrombopoietin (TPO) levels in hepatic patients with thrombocytopenia.The role of thrombopoietin in the thrombocytopenia of patients with liver cirrhosis.Review article: thrombocytopenia in chronic liver disease and pharmacologic treatment options.Causes of thrombocytopenia in chronic hepatitis C viral infection.Proton beam therapy reduces the incidence of acute haematological and gastrointestinal toxicities associated with craniospinal irradiation in pediatric brain tumors.Serum thrombopoietin levels and its relationship with thrombocytopenia in patients with cirrhosis.Romiplostim treatment allows for platelet transfusion-free liver transplantation in pediatric thrombocytopenic patient with primary sclerosing cholangitis.Management of thrombocytopenia in advanced liver diseaseDeterminants of platelet count are different in patients with compensated and decompensated cirrhosis.Non-ALT biomarkers for markedly abnormal liver histology among Chinese persistently normal alanine aminotransferase-chronic hepatitis B patientsThe utility of thrombopoietin in predicting liver fibrosis in chronic hepatitis B.Pegylated-interferon-α(2a) in clinical practice: how to manage patients suffering from side effects.Correlation of aspartate aminotransferase/platelet ratio index with hepatic venous pressure gradient in cirrhosisDeficiency in thrombopoietin induction after liver surgery is associated with postoperative liver dysfunction.Comparison of histologic characteristics of Chinese chronic hepatitis B patients with persistently normal or mildly elevated ALTSerum ceruloplasmin levels correlate negatively with liver fibrosis in males with chronic hepatitis B: a new noninvasive model for predicting liver fibrosis in HBV-related liver disease.Factors associated or related to with pathological severity of nonalcoholic fatty liver disease.Predictors for Early Identification of Hepatitis C Virus InfectionAST to Platelet Ratio Index Predicts Mortality in Hospitalized Patients With Hepatitis B-Related Decompensated Cirrhosis.GlycoFibroTest is a highly performant liver fibrosis biomarker derived from DNA sequencer-based serum protein glycomics.Abnormal hematological indices in cirrhosis.Novel non-invasive biological predictive index for liver fibrosis in hepatitis C virus genotype 4 patientsPostoperative aspartate aminotransferase to platelet ratio index change predicts prognosis for hepatocellular carcinomaImprovement of platelets after SVR among patients with chronic HCV infection and advanced hepatic fibrosis.A novel predictive model using routinely clinical parameters to predict liver fibrosis in patients with chronic hepatitis B.The diagnostic accuracy of the Forns index, platelet count and AST to Platelet Ratio Index derived fibrosis index for the prediction of Hepatitis C virus-related significant liver fibrosis and cirrhosis.A new model using platelet indices to predict liver fibrosis in patients with chronic hepatitis B infection.A simple, noninvasive test for the diagnosis of liver fibrosis in patients with hepatitis C recurrence after liver transplantation.Management and treatment of hepatitis C viral infection: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center program and the National Hepatitis C Program office.Clinicopathological features of recurrence in patients after 10-year disease-free survival following curative hepatic resection of hepatocellular carcinoma.Association of Nonalcoholic Fatty Liver Disease and Venous Thromboembolism in Women With Endometrial Cancer.Immature platelet fraction and thrombopoietin in patients with liver cirrhosis: A cohort study.Clinical study on the relationship between hematocytopenia and splenomegaly caused by cirrhotic portal hypertension.Predictive value of serum globulin levels for the extent of hepatic fibrosis in patients with chronic hepatitis B infection.Risk of reduced platelet counts in patients with nonalcoholic fatty liver disease (NAFLD): a prospective cohort study
P2860
Q26749277-4D45261A-B84F-4BC9-B69D-252BC9278ED9Q26865956-BAE9B386-E20A-48BC-8BB4-117B9B73C03EQ30358189-2FA03E85-C3DB-4554-89DF-2D5D083E3E6DQ30406744-518EAE4F-EB31-4BDD-906A-25C728D800D4Q30476922-04021B6B-2B33-4645-99D4-9A7CCD5A8617Q33365357-4DBD5AFD-7293-4D26-BA82-CB33EDC759BBQ33366601-24F86F32-61C2-4D17-BC49-3A8755791EA7Q33370831-B39016AA-6472-4391-949B-B9450D4A6110Q33399654-952EC2B8-48D4-4017-BBEE-3AC67BB2FB19Q33415836-DA454CA3-7A67-44C7-80E0-794189EFF2C6Q33416172-D03F3BE4-EF82-4ED7-8A8A-EABA7B114694Q33416575-25C0C369-0C02-438D-8B36-B26BDC0B98EFQ33417667-98A3F2C5-EAA0-4857-9D36-A262730B52ECQ33424074-6EA8DFC8-A1BE-46F4-A27A-A3D96B856D56Q33599576-0CF61636-DBF7-490A-AF0B-C2E390223183Q33816016-E3C1249E-ECB8-4B09-8103-105DCEEF7354Q34164776-02B68387-BCCD-4D63-A8C0-4ECAC5068E3BQ34418673-9EBE6943-CC28-498F-9968-B44AC2A3B3BBQ35001606-A75CC2C8-DDF2-47FD-A71F-D121C3CEE53DQ35049139-1E9A7221-C1D0-4714-B396-B44563CDEEA2Q35054972-D431F4ED-17DA-4253-BCAF-583F4D62D165Q35936850-97EC51AB-2CA4-480B-A451-CD31427A0CBEQ36043559-F3E7060C-5043-454A-A76F-A3281A8D575BQ36664042-A5F0AF42-3ECE-4A07-A98F-60F5508AC3F0Q37210696-FF247BBC-6FBD-46BD-94DE-951B6D8DFBFAQ37291711-7FE52681-B906-4F39-B6CA-9883FC71F85EQ37421485-86101DE1-C94D-42B7-A6D6-BEC20A7593C0Q37605578-93D7EFBC-C455-46C3-AF55-DBA8DB3789EBQ40878925-A827882F-F741-412D-A2AD-E5035364165AQ41708878-416CDD6C-7266-4CDC-8B63-39B4AFC7EFAFQ42241447-4BED9533-4528-4FED-9CFB-76AF48363042Q42254850-58C37ED7-AAF1-4000-82C4-C23B877E2EB8Q43239556-A8C13A06-19BE-4F0B-B037-81FB1921AAA9Q44097379-B77A8E55-BF63-495F-B309-453FE3B0F4DDQ45036838-8CDFDC0D-FEBC-40D8-97A3-04CD791AD9A5Q46494101-341F9B1C-2049-403A-A408-3651A76E787DQ50041720-00C75F58-4BE2-4D7E-B31E-CD99C6D44735Q50474973-74D39D69-AAEF-434A-9032-49B8B421B4ECQ53249817-9C18F427-CC35-4B94-88E3-653A6834152DQ58720850-348A7EA7-8085-45DE-99DF-2CA46F9D6147
P2860
Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis.
@ast
Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis.
@en
Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis.
@nl
type
label
Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis.
@ast
Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis.
@en
Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis.
@nl
prefLabel
Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis.
@ast
Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis.
@en
Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis.
@nl
P2093
P2860
P1476
Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis.
@en
P2093
Kageyama F
Kawasaki T
Kikuyama M
Kobayashi Y
Murohisa G
Nakamura H
P2860
P304
P356
10.1111/J.1572-0241.1999.01231.X
P407
P577
1999-07-01T00:00:00Z